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The mouse and human β2-microglobulin protein orthologs are 70 % identical in sequence and share 88 %
sequence similarity. These proteins are predicted by various algorithms to have similar aggregation and amyloid
propensities. However, whilst human β2m (hβ2m) forms amyloid-like fibrils in denaturing conditions (e.g. pH 2.5)
in the absence of NaCl, mouse β2m (mβ2m) requires the addition of 0.3 M NaCl to cause fibrillation. Here, the
factors which give rise to this difference in amyloid propensity are investigated. We utilise structural and
mutational analyses, fibril growth kinetics and solubilitymeasurements under a rangeof pHand salt conditions, to
determine why these two proteins have different amyloid propensities. The results show that, although other
factors influence the fibril growth kinetics, a striking difference in the solubility of the proteins is a key determinant
of the different amyloidogenicity of hβ2m and mβ2m. The relationship between protein solubility and lag time of
amyloid formation is not captured by current aggregation or amyloid prediction algorithms, indicating a need to
better understand the role of solubility on the lag time of amyloid formation. The results demonstrate the key
contribution of protein solubility in determining amyloid propensity and lag time of amyloid formation, highlighting
how small differences in protein sequence can have dramatic effects on amyloid formation.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
β2-microglobulin (β2m) is the light chain of the
class I major histocompatibility complex [1]. This
99-residue protein (Fig. 1a) is associated in humans
with dialysis-related amyloidosis (DRA) and in rare
instances, familial amyloidosis [1–4]. In healthy
individuals human β2m (hβ2m) is degraded and
excreted by the kidneys; however β2m concentra-
tions increase more than 50-fold in the plasma of
patients on long-term hemodialysis [1]. This increase
in β2m concentration is thought to facilitate aggre-
gation of hβ2m into amyloid fibrils, which form
systemic deposits, most notably in the osteoarticular
tissues [1–10]. In mice, the serum levels of β2m are
100-times higher than in healthy humans, and N 5
times higher than in humans on dialysis [4].
However, despite these high serum concentrations,
amyloid deposits of β2m are not observed in mice [4].
This striking difference in the behaviour of β2m in
vivo appears counterintuitive as the mouse β2mAuthors. Published by Elsevier Ltd. T
rg/licenses/by/4.0/).(mβ2m) and hβ2m sequences are 70 % identical,
share 88 % sequence similarity and the native
proteins have very similar structures (Fig. 1a,b).
Several algorithms predict the propensity for
proteins to aggregate and/or form amyloid based
on the protein sequence alone [11–16]. These
prediction algorithms (Fig. 1c-h) highlight the
E-strand of β2m as either being one of the most, or
the most, aggregation-prone region(s) of the protein.
Only minor differences between the predictions for
the mβ2m and hβ2m sequences are identified,
consistent with the high sequence similarity of the
proteins (Fig. 1 c-h). Yet despite the predicted
amyloidogenicity of hβ2m, monomeric hβ2m does
not form amyloid fibrils de novo at neutral pH in vitro,
without the addition of cofactors such as heparin,
SDS, or Cu2+ or by the truncation of the protein
[2,7,9,10]. However, upon unfolding by acid dena-
turation and agitation, hβ2m rapidly forms fibrils with
a parallel in register cross-beta structure typical of
amyloid [17,18]. Since the aggregation propensityhis is an open access article under the CC BY license
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Fig. 1. Human and mouse β2m have high sequence and structural similarity. (a) Ribbon diagram showing the
structural alignment of hβ2m (PDB: 2XKS [10]), and mβ2m (PDB: 1LK2 [51]) crystal structures, coloured in grey and blue,
respectively. The E-strand is coloured in yellow and the FG-loop in red in each structure. The figure was created using
PyMol [52]. (b) Sequence alignment of hβ2m and mβ2m with the E-strand and the FG loop highlighted in pale yellow and
red, respectively. Identical residues are boxed in grey. (c) CamSol solubility prediction profiles at pH 2, with threshold
values for soluble (+1) and insoluble (-1) regions shown [11]; (d) Zyggregator amyloid propensity prediction profiles for
pH 2, with the threshold value for aggregation-prone regions shown (≥1) [14]; (e) TANGO aggregation prediction profiles
for pH 2, indicating the percentage likelihood of a region being aggregation-prone, with the threshold value (N 5 %) for
aggregation-prone sequences shown [53]; (f) WALTZ amyloid prediction profiles for pH 2.6, indicating the percentage
likelihood of a sequence being able to form amyloid [13]; (g) Aggrescan aggregation profiles indicating the “normalised
hotspot area” for aggregation-prone regions [12]; and (h) AmylPred consensus profile where regions with a value of +1 are
predicted to have a high propensity to form amyloid. The algorithm parameters closest matching the low pH fibril growth
buffer were chosen where possible. In c-h hβ2m is in black and mβ2m is in blue.
632 Protein solubility and amyloid formationfor the human and mouse β2m sequences is
predicted to be similar it would be expected that
mβ2m, like hβ2m, would also aggregate when acid
unfolded. Surprisingly, in vitro studies have shown
that mβ2m does not form fibrils under these
conditions (i.e. low pH with agitation) [4,10,19].
Since the extent of the difference in amyloidogeni-
city of mβ2m and hβ2m is so marked and different
prediction methods fail to capture this difference
(Fig. 1c-h), these sequences provide an ideal model
to interrogate the key determinants of amyloidogeni-
city [4,10,19]. Here, the conformational properties
and sequence changes that give rise to the observed
difference in amyloid propensity between humanand mouse β2m are analysed through structural and
mutational analyses, fibril growth kinetics and
solubility measurements. The results demonstrate
that small sequence changes have a dramatic effect
on the solubility and the lag time of amyloid formation
in these acid-unfolded proteins. The results add to a
growing body of evidence indicating that protein
solubility is an important determinant of amyloid
propensity even in the absence of structural factors
[11,14,20–35]. Importantly, current algorithms are
unable to reliably predict the differences in lag time of
fibril formation observed for the mβ2m and hβ2m
sequences. Improving our ability to predict the effect
of residues flanking amyloid-prone regions on
633Protein solubility and amyloid formationaggregation, and how sequence differences affect
solubility, may allow for a greater understanding of
the lag time of amyloid formation and how protein
variants associated with disease cause protein
aggregation in vivo.Results
Ionic strength and the aggregation of mβ2m
Previous studies of acid-unfolded mβ2m showed
that the protein is unable to form amyloid fibrils by
quiescent incubation, even in the presence of 1.5 M
NaCl (in 25 mM sodium phosphate, pH 2.0 at 37 °C)
[4]. By contrast, hβ2m forms fibrils within 3 hours
under identical conditions [4]. Here, to investigate
the amyloidogenicity of mβ2m and hβ2m in more
detail, mβ2m was incubated in pH 2.5 fibril growth
buffer (25 mM sodium phosphate/25 mM sodium
acetate) at 37 °C and agitated at 200 rpm (Fig. 2a)
[36–38]. Consistent with previous results [4,10,19],
mβ2m did not form fibrils under these conditions
(Fig. 2a). Furthermore, addition of 10 % (v/v) hβ2m
fibril seeds formed at pH 2.5 (see Materials and
Methods [36,39]) did not induce fibril growth
(Fig. 2a). By contrast with these results, in the
presence of 0.3 M NaCl and agitation at 200 rpm
fibril growth was observed for mβ2m at pH 2.5
(Fig. 2a) with the lag time being reduced upon the
addition of 10 % (w/w) fragmented mβ2m fibrils
formed in the presence of 0.3 M NaCl, consistent
with a seeding reaction (Fig. 2a). Interestingly mβ2m
fibrils did not seed in 0 M NaCl, pH 2.5 and hβ2m
seeds did not initiatemβ2m fibrillation in 0.3 M NaCl,
pH 2.5 (data not shown). Negative-stain EM images
confirmed the presence of amyloid-like fibrils of
mβ2m in the presence of 0.3 M NaCl, but not in the
absence of NaCl (Fig. 2b), confirming the require-
ment of higher ionic strength conditions to facilitate
self-assembly of mβ2m even when the protein is
unfolded at acidic pH.
Next, a systematic investigation of the effect of
ionic strength on fibril formation by mβ2m was
performed (Fig. 3a). As observed previously for
acid unfolded hβ2m [38,40], there is an optimum
NaCl concentration at which the shortest lag time for
fibril growth occurs (0.6 M NaCl for mβ2m at pH 2.5)
(Fig. 3b) [40]. As Yoshimura et al. noted for hβ2m,
this is most likely due to a charge-balance require-
ment for fibril formation: electrostatic repulsion must
be overcome in order for the protein subunits to
interact, but too many interactions can trap the
protein in off-pathway soluble oligomers or amor-
phous insoluble aggregates slowing down amyloid
formation. This rationale is supported by the obser-
vation thatmβ2m forms abundant short fibrils at ionic
strengths N 0.6 M (Fig. 3c). The fibrils of mβ2mformed in 0.3 M NaCl were the longest and most
dispersed of all conditions investigated (Fig. 3c).
Thus, this salt concentration was chosen for further
experiments.
Conformational properties of denatured β2m and
the determinants of amyloidogenicity
A contributing factor to the different amyloid
propensities of mβ2m and hβ2m could be differences
in their conformational properties at pH 2.5. To
compare the conformations of the acid denatured
states of these proteins CD, 1H- 15N HSQC NMR
spectra and the binding of anilino-1-naphthalenesul-
fonate (ANS) to each protein were assessed at pH 2.5
(SI Fig. 1a-f). The far-UV CD spectra show that both
proteins are highly unfolded at pH 2.5 (SI Fig. 1a and
b), consistent with the limited 1H dispersion observed
in the 1H- 15N HSQC spectra of each protein which
is also indicative of an unfolded protein ensemble
(SI Fig. 1c and d). Interestingly, the far-UVCD spectra
of mβ2m and hβ2m are different. This is likely due to
differences in the aromatic contributions to the spectra
of the native proteins at neutral pH and subtle
differences in the populations of species in the
unfolded ensembles at pH 2.5 (SI Figs. 1a and b).
ANS fluorescenceemission spectra showno increase
in fluorescence intensity and no change in the
fluorescence emission λmax for mβ2m and hβ2m in
0.3 M NaCl compared with 0 M NaCl, ruling out
substantial differences in the distribution of solvent
exposed hydrophobic patches in the two acid unfold-
ed proteins (SI Fig. 1e). Furthermore, even in the
presence of NaCl no significant conformational
changes were detected for the mβ2m acid unfolded
ensemble, as detected byANSbinding and far-UVCD
(SI Fig. 1e and f). Together these results show that
gross differences in the residual structure of acid
denatured mβ2m and hβ2m are unlikely to be
responsible for the differences in their amyloid
propensity observed.
There are fewer peaks in the 1H- 15N HSQC
spectrum of hβ2m in pH 2.5 buffer compared with
that of mβ2m under the same conditions (SI Fig. 1c
and d). The line broadening that causes the loss of
peaks in the 1H- 15N HSQC spectrum of hβ2m may
indicate conformational exchange on the micro- to
millisecond timescale and/or oligomerization of the
protein, which could be linked to the increased
aggregation propensity of hβ2m. To investigate the
relationship between line broadening and amyloido-
genicity, a series of 1H- 15N HSQC spectra were
acquired. Spectra of mβ2m were recorded in pH 2.5
water, 25 mM sodium phosphate/ 25 mM sodium
acetate (pH 2.5), and the same buffer containing
either 0.3 M or 0.8 M NaCl (SI Fig. 2). The spectra
show that as the salt concentration is increased the
line broadening is also increased and peaks are lost
from the spectra. In 0.8 M NaCl only 20 of the total
Fig. 2. mβ2m forms fibrils in the presence of NaCl. Fibril growth kinetics at pH 2.5 of 50 μM mβ2m agitated at
200 rpm and monitored by ThT fluorescence in the absence (closed data points) or presence of 0.3 M NaCl (open data
points). Unseeded reactionsare colouredblue. Seededgrowth experiments (grey) were performed in0 MNaClwith 10% (v/v)
hβ2m fibril seeds formed in fibril growth buffer (pH 2.5) with 0 M NaCl, or in 0.3 M NaCl with 10 % (v/v)mβ2m fibril seeds
formed in fibril growth buffer with 0.3 M NaCl. Three replicates of each condition are shown. (b) The endpoint negative
stain EM images of the above reactions after 24 hours incubation are shown as indicated (see Materials and Methods).
634 Protein solubility and amyloid formation73 peaks are visible (SI Fig. 2d). Since these peaks
reappear with the addition of 8 M urea this is not a
consequence of the high salt conditions affecting data
acquisition (SI Fig. 3). To investigate whether the
oligomerization of the protein contributes to the line
broadening, sedimentation velocity analytical ultra-
centrifugation (AUC) was performed on the samples
(SI Fig. 4). These results revealed that mβ2m is
predominantly a single species at pH 2.5, with a
weight-averagedS20,w value of 1.23S, consistent with
a monomeric species of β2m [41]. However, higher
order species are observed in 0.3 M NaCl and 0.8 M
NaCl. In 0.8 M NaCl the protein is predominantly
dimeric and in higher order oligomers (SI Fig. 4),consistent with the line broadening observed in the
NMR spectra obtained in 0.8 M NaCl (SI Fig. 2d).
These results suggest that increased concentrations
of NaCl favour aggregation, at least in part, by
increasing the likelihood of the formation of oligomers
that can initiate aggregation.
Sequence determinants of amyloidogenicity
The E-strand is the most amyloidogenic β-strand
of the β2m sequence [36,42]. There are two
differences between the sequence of mβ2m and
that of hβ2m in this region (Y66 and Y67 in hβ2m,
A66 and H67 inmβ2m) (Fig. 1b). These substitutions
Fig. 3. Fibrillation ofmβ2m is dependent on NaCl concentration. (a) Fibril growth kinetics of 50 μMmβ2m agitated at
200 rpm andmonitored by ThT fluorescence at pH 2.5 in the presence of 0.1 - 0.8 M NaCl. (b) Lag time analysis of the fibril
growth curves shown in (a). In cases where no fibrils were observed the lag time is plotted with a value of 20 hours as a
lower limit for an indefinite lag time. (c) Negative-stain EM images after 24 hours incubation ofmβ2m in pH 2.5 fibril growth
buffer with 0.3 M NaCl, 0.6 M NaCl or 0.8 M NaCl, as indicated. The scale bar for 0.8 M NaCl is different to that of 0.3 and
0.6 M NaCl because the fibrils were considerably smaller.
635Protein solubility and amyloid formationresult in differing aggregation propensity for this
region, with mβ2m predicted to be marginally less
aggregation prone than its human counterpart using
three of the aggregation prediction algorithms tested
(Fig. 1d,e,g). To determine whether the difference in
amyloid propensity of mβ2m and hβ2m is related to
the sequence differences in this region, the E-stand
of both β2m variants were synthesised as peptides.
Incubation of these peptides at pH 2.5 resulted in
fibril formation of both peptides immediately upon
dilution out of DMSO into fibril growth buffer (data not
shown). Fibrils were confirmed by negative-stain
transmission EM (SI Fig. 5), ruling out sequence
differences in this region as the major contributing
factor to the very different amyloid propensities of
their parent protein sequences.
Previously Ivanova et al. attributed the differences
in amyloidogenicity of mβ2m and hβ2m to the FG
loop region [4]. The group made chimeric proteins, in
which the FG loop sequence (residues 83-89) of
hβ2m was replaced by the corresponding region
frommβ2m to create hβ2m(M7). The complementary
protein mβ2m(H7) was generated by replacing
residues 83-89 of mβ2m with the corresponding
hβ2m sequence (Fig. 4a). Their analysis of the
chimeric proteins revealed that hβ2m(M7) aggregat-
ed more slowly than hβ2m at pH 2.0 under quiescent
conditions in 200 mM NaCl. Conversely, mβ2m(H7)formed fibrils, whereas the wild-type mβ2m se-
quence did not [4]. We analysed the aggregation
kinetics of hβ2m(M7) andmβ2m(H7) at different ionic
strengths at pH 2.5 (Fig. 4b and c). No fibril growth
for mβ2m or mβ2m(H7) was observed in 0 M NaCl
after incubation and shaking (200 rpm) for 60 hours
(Fig. 4b). By contrast, the hβ2m(M7) aggregated at a
similar rate as its hβ2m counterpart in 0 M NaCl (lag
times 4.2 ± 1.1 hours, 5.5 ± 1.1 hours, respectively)
(Fig. 4b, Table 1). In 0.3 M NaCl all four proteins
formed fibrils within 60 hours, although hβ2m(M7)
aggregated more slowly than hβ2m (lag time of
13.7 ± 1.5 hours, 9.2 ± 0.6 hours, respectively)
(Fig. 4c). In 0.3 M NaCl, a dramatic effect on the
behaviour of mβ2m(H7) was observed, in which the
lag time is reduced substantially when compared
with mβ2m (lag times 4.1 ± 0.5 hours, 30.1 ±
4.5 hours, respectively) (Fig. 4c, Table 1). This
striking 7-fold reduction in lag time confirms that
the FG loop region of hβ2m is responsible, at least in
part, for the enhanced amyloid propensity of the
mβ2m(H7) sequence. Interestingly, the lack of such
a dramatic effect in the hβ2m(M7) sequence com-
pared with hβ2m indicates that the effect is depen-
dent both on the sequence of the FG loop and that of
the host protein.
To investigate how solubility contributes to the lag
time of amyloid formation for mβ2m, mβ2m(H7),
Fig. 4. Sequence determinants of β2m amyloidogenicity. (a) Sequence alignment of the chimeric proteins hβ2m(M7)
and mβ2m(H7) in which regions 83-89 of hβ2m have been replaced with the corresponding residues in mβ2m and vice
versa. The regions that are switched are shown in red (b) Fibril growth kinetics of 50 μM protein agitated at 200 rpm
monitored by ThT fluorescence at pH 2.5 in (b) 0 M or (c) 0.3 M NaCl. Data formβ2m,mβ2m(H7), hβ2m and hβ2m(M7) are
shown as closed blue, open blue, closed black and open black data points, respectively. End-point negative stain EM
images of hβ2m,mβ2m(H7) and hβ2m(M7) in 0 M or 0.3 M NaCl are shown in the lower panels of (b) and (c), respectively.
EM images of mβ2m in 0 M NaCl or 0.3 M NaCl are shown in Fig. 2b.
636 Protein solubility and amyloid formationhβ2m and hβ2m(H7) the dependence of the lag times
of fibril growth on ionic strength and the solubility of
each protein was measured in the different condi-
tions used. The critical concentration (Cs) is the
protein concentration at which phase separation
occurs, thus any protein molecules above this
concentration will, eventually, become insoluble
[11,25]. Many proteins can remain soluble above
their critical concentration. Such supersaturated
proteins are kinetically, but not thermodynamically,
stable [31,34]. The higher the protein concentration
is above the critical concentration, the greater the
driving force for aggregation [11,25,31]. Therefore
the Cs of fibril formation can be used as a measure of
solubility and reports on the driving force of
aggregation. To determine the Cs for the different
proteins studied in 0 M or 0.3 M NaCl, each protein
was incubated for 14 days (with agitation) at pH 2.5
in the absence or presence of 0.3 M NaCl at 37 °Cand soluble protein was then separated from
insoluble protein by centrifugation (Materials and
Methods). These experiments revealed thatmβ2m is
substantially more soluble than its human counter-
part in the absence of NaCl (Fig. 5a). Indeed, in the
absence of NaCl mβ2m remains ≥ 90 % soluble
even at a protein concentration of 1.4 mM (Fig. 5a
inset). The Cs of mβ2m in 0 M NaCl is N 1.4 mM,
compared with only 11 ± 4 μM in 0.3 M NaCl
(Fig. 5b, Table 1). By contrast, hβ2m is substantially
less soluble than mβ2m at both ionic strengths
(Fig. 5b, Table 1). These results correlate with the
marked difference in the lag times of the two proteins
in the different solution condition used.
To explore the effect of the FG loop on protein
solubility the critical concentrations of the chimeric
proteins were also measured and compared with the
corresponding values for wild-typemβ2m and hβ2m in
0.3 M NaCl (Fig. 5c and d). At this ionic strength there
Table 1. – Lag times of amyloid formation and solubility of
different β2m variants
0 M NaCl 0.3 M NaCl
Protein Lag-timea
(Hours)
Cs (μM)
b Lag-timea
(Hours)
Cs (μM)
b
hβ2m 5.5 ± 1.1 2.7 ± 0.5 9.2 ± 0.6 2.9 ± 0.4
mβ2m N 60 N 1400 30.1 ± 4.5 11.0 ± 4.3
hβ2m(M7) 4.2 ± 1.1 n.d. 13.7 ± 1.5 4.3 ± 0.5
mβ2m(H7) N 60 n.d. 4.1 ± 0.5 3.4 ± 0.8
aLag time determined by fitting a straight line to the steepest part of
the slope of the growth phase (see Material and Methods).
bCritical concentration determined by agitated incubation of
various concentrations of protein and measuring the protein
concentration of the supernatant after 2 weeks (see Materials and
Methods). n.d., not determined.
637Protein solubility and amyloid formationis a clear relationship between lag time and the Cs of
each protein (Fig. 5d, Table 1).mβ2m has a higher Cs
and a longer lag time than mβ2m(H7) (Cs values ofFig. 5. mβ2m is more soluble than hβ2m at pH 2.5. (a) Fin
of mβ2m or hβ2m shown in blue and black, respectively. Samp
points) or 0.3 M (open data points) NaCl at 37 °C. Error bars a
and smaller than the data points if not visible. Data were fitte
concentration (Cs) (see Materials and Methods for details). (b) T
the same experimental conditions. Data formβ2m (Cs and lag t
as no aggregation was detected under the conditions used
mβ2m(H7), hβ2m and hβ2m(M7) incubated at pH 2.5 with 0.3 M
lag time of fibril growth under the same experimental condition11.0 ± 4.3 μM and 3.4 ± 0.8 μM, respectively). hβ2m
and hβ2m(M7) have Cs values 2.9 ± 0.4 μM and
4.3 ± 0.5 μM, respectively in 0.3 M NaCl, compared
with 2.7 ± 0.5 μM for hβ2m in 0 MNaCl. Nonetheless,
these proteins have lag times that are 1.7- and 2.5-fold
longer, respectively, than hβ2m in 0 M NaCl (Fig. 5d,
Table 1). This lack of correlation between Cs and lag
time could be due to the hβ2m sequence being at its
optimal solubility for amyloid formation and, therefore,
other effects start to dominate the lag time of amyloid
formation, such as non-specific amorphous aggrega-
tion or specific ion binding [5,6,22,38,40].Discussion
Solubility and amyloidogenicity
Previous work by Ivanova et al. attributed the low
amyloidogenicity of mβ2m to sequence differencesal soluble protein concentration measured after incubation
les were agitated for 14 days at pH 2.5 in 0 M (closed data
re the standard deviation of three replicate measurements
d to determine the plateau regions, and hence the critical
he Cs is plotted alongside the lag time of fibril growth under
ime) are shown as N1400 μM and N60 hours, respectively,
. (c) The final soluble protein concentration for mβ2m,
NaCl are plotted. (d) The Cs values plotted alongside the
s.
Fig. 6. Conceptual schematic energy landscape of β2m aggregation at low pH. The solubility of a protein depends
on the free energy difference between its monomeric and aggregated states. Formation of amyloid and amorphous
aggregates (the aggregation propensity) depends on the activation free energy barrier between monomer and aggregate/
amyloid and is therefore kinetically governed. The reaction could be more complicated than shown here since amorphous
aggregates can be formed on-pathway or in competition with amyloid aggregates. In addition, each of the free energy
differences will depend on the protein sequence (including point mutations and/or other larger sequence changes such as
the hβ2m/mβ2m chimeras), pH, solution conditions (i.e. salt concentration) and protein concentration. The diagram should
thus be used for conceptual purposes to show that hβ2m has a greater amyloid propensity and lower solubility compared
with mβ2m.
638 Protein solubility and amyloid formationin the FG-loop [4]. The results presented here concur
with this view and reveal that this difference in
amyloid propensity results predominantly from the
effect of the FG-loop on protein solubility (Fig. 5).
The acid unfolded states of hβ2m andmβ2m are both
disordered (SI Fig. 1), therefore, it is unlikely that
structural differences alone could explain the differ-
ent amyloid propensities of the two sequences. The
results thus highlight the critical role of protein
solubility in determining the aggregation propensities
of these two sequences.
Previous research has linked the aggregation of
acid denatured hβ2m to its solubility [20], and work
by Goto & colleagues has proposed a phase
diagram for ordered assembly of acid unfolded
hβ2m into amyloid fibrils, suggesting that protein
solubility has an important role in aggregation and in
the nucleation mechanism [26,40]. Routledge et al.
previously showed that they were able to better
predict the aggregation rates of different hβ2m
variants at pH 2.5 by taking NMR relaxation proper-
ties (a measure of conformational dynamics and/or
intermolecular interaction) into account [37]. Here we
show that by increasing the ionic strength of the
solution and unfolding the protein at low pH,mβ2m is
able to form amyloid-like fibrils. Yet mβ2m does not
aggregate in the absence of 0.3 M NaCl because theCs of the protein is N 1.4 mM at lower ionic
strengths. Subtle changes in the protein sequence
and solution conditions, thus, can have dramatic
effects on solubility and, in turn, on the lag time of
amyloid formation. Interestingly the sequence in the
native E-strand of hβ2m has been shown to be
critical for determining the rate of amyloid formation
in the acid unfolded state, with the remainder of the
sequence having little effect on the rate of amyloid
formation [36,37,42]. These residues form only 11
out of a total 70 residues in the core of hβ2m amyloid
fibrils, which span residues G18-Q88 [43]. There-
fore, while the sequence of the E-strand is solely
important for determining the kinetics of aggregation,
it is not necessarily central to thermodynamic
stability of the fibril architecture. This example
demonstrates that a greater understanding of the
interplay between protein sequence and the driving
force of aggregation that causes a metastable
supersaturated protein to aggregate (Fig. 6).
Consequences for amyloid formation in general
The FG loop region of mβ2m is predicted to be
more soluble than its hβ2m equivalent by the
CamSol intrinsic protein solubility prediction algo-
rithm (Fig. 1c) [11], but to have only a modest effect
639Protein solubility and amyloid formationon the aggregation/amyloid propensity of the se-
quences (Fig. 1d-h). In contrast, our results show
this region has a significant effect on the lag time of
amyloid formation. In seminal work by Chiti et al. the
effects of amino acid substitutions on the rates of
aggregation of the denatured sate of human acyl-
phosphatase (AcP) were investigated [44]. The
authors showed that the aggregation rates could
be correlated with three physiochemical properties
of the protein sequence; hydrophobicity, secondary
structure propensity and charge [44]. These proper-
ties together are able to predict the trends in
aggregation rates observed for disease-relevant
peptides and natively unfolded proteins such as
amylin, Aβ-peptide, tau and∝-synuclein [44]. These
observations were the foundation for Zyggregator,
an algorithm which aims to predict the absolute
aggregation rate for a given protein sequence [45].
Importantly these rates are predicted for proteins
above their Cs and represent the elongation rate of
amyloid fibrils rather than the nucleation rate or lag
time [14,45]. Other prediction algorithms aim to find
the most amyloid-prone or aggregation-prone re-
gions within a sequence, but are not able to predict
rates of nucleation or elongation [12,13,15,16].
Rousseau et al. have analysed the proteomes of
28 different organisms through the TANGO aggre-
gation prediction algorithm [46]. This algorithm
balances factors such as hydrophobicity, hydrogen
bonds, secondary structure propensities and charge
to predict sequence segments with high aggregation
propensity [16]. Their results showed there is a
selective pressure against aggregation-prone se-
quences, but also that when aggregation-prone
regions are present there is a strong evolutionary
pressure towards “gate-keeper” residues within the
flanking regions [46]. Protein aggregation into
amorphous or ordered aggregates is kinetically
controlled, whilst solubility is thermodynamically
governed (Fig. 6). However, there is an unavoidable
correlation between aggregation rate and solubility
given that similar physiochemical properties of the
amino acid sequence govern each process [11].
These gate-keeper residues include proline, arginine
and lysine which increase solubility and their
incorporations in the flanking regions of aggrega-
tion-prone sequences reduces aggregation propen-
sity and amyloid formation [46]. There are twenty-two
residues that are different between mβ2m and hβ2m
(Fig. 1b). Of these residues, ten are charge swapping
amino acid substitutions. Seven of the ten are charged
in hβ2m and substituted with neutral residues in
mβ2m. One of the ten is a charge reversal, and the
remaining two residues are neutral in hβ2m but
charged in mβ2m. Interestingly, these two residues
are in the FG-loop region, and only one would be
charged at pH 2.5. There are also four additional
proline residues in the mβ2m sequence when
compared with hβ2m sequence, which may play arole in protecting the sequence from aggregation into
amyloid. Although these prolines would be predicted
to reduce amyloid propensity, they are spread
throughout the sequence, which may explain why
mβ2m sequence is still able to adopt an amyloid
structure when conditions are favourable.
The sequence differences in the FG-loop have a
significant effect on the solubility ofmβ2m and hβ2m,
however this region alone is insufficient to fully
confer the difference in solubility betweenmβ2m and
hβ2m suggesting that other parts of the β2m
sequence contribute to the overall solubility of the
sequence. The 4-residue flanking regions either side
of the E-strand are identical in both proteins and
hence differences in the residues that flank the most
aggregation-prone regions cannot be responsible for
the difference in aggregation of mβ2m and hβ2m.
Together, the results indicate that the entire protein
sequence must be considered to understand the
solubility and amyloidogenicity of a protein se-
quence, even for an unfolded protein.
The effects of protein solubility on amyloid
formation in vitro have been highlighted recently in
several systems. The flanking regions of polygluta-
mine repeat sequences can have a dramatic effect
on solubility, affecting aggregation rates, as well as
the nucleation mechanism [25]. The H50Q variant of
α-synuclein has been shown to have decreased
solubility which correlates with the decreased lag time
of the protein compared with the wild-type sequence
[24]. Experiments by Goto and colleagues have
revealed that sonication can alter protein solubility at
the air water interface and hence aid the initiation of
amyloid formation [40]. These studies, together with
the work presented here, highlight the importance of
protein solubility in determining the rates of protein
aggregation and reveal how differences in experi-
mental design (i.e. surface area of the air water
interface, vessel material, method of agitation, salt
concentration, type of salt used) and subtle differ-
ences in sequence can affect the observed lag times
of amyloid formation such that a protein such asmβ2m
can escape from aggregation at mM concentration
and low ionic strength.
Human and mouse β2m provide a particularly
striking example in which solubility determines
amyloid formation. The discrepancy between the
dramatic difference in the rates of aggregation of
hβ2m and mβ2m, with the relatively subtle differ-
ences in the predicted protein solubility (Fig. 1c) and
aggregation propensity (Fig. 1d-h), highlights the
need for a greater understanding of how sequence
alters protein solubility and how amino acid substi-
tutions modulate solubility in a sequence- and
region-dependent manner. Here we have shown
that a protein that is very soluble and yet contains
sequences with high amyloid propensity (e.g. the
E-strand of mβ2m), does not aggregate in 0 M NaCl
since it contains solubi l is ing amino acid
640 Protein solubility and amyloid formationsubstitutions, including residues in the FG-loop,
compared with hβ2m. The solubility (i.e. the Cs) is
the driving force for aggregation and a key determi-
nant of the lag time of amyloid formation of these
unfolded proteins. Nonetheless, the lag time is a
largely underutilised parameter for testing amyloid
prediction algorithms. This was recently noted by
Hall et al. who theorised that an understanding of
protein solubility and how this effects the competition
between amyloid and amorphous aggregation
mechanisms may be informative for understanding
the cause and age of onset of amyloid disease [22].
Since most proteins are on the edge of solubility [29],
and many are already supersaturated in the cell [31],
an enhanced ability to predict Cs accurately, and the
effects of environmental factors in modulating
solubility, could enable us to elucidate the tipping
point at which a soluble protein will become
aggregation-prone and could cause disease. De-
tailed investigation of protein solubility, and the
effects of sequence and experimental conditions
on Cs and the lag time of aggregation such as
presented here for hβ2m, mβ2m and their chimeras,
will be needed for many protein sequences in order
to derive such an understanding.Materials and Methods
Protein preparation
The synthetic E.coli codon optimised genes (Eurofins
Genomics) for the chimeric proteins hβ2m(M7) and
mβ2m(M7) were removed from the pEX-A vector with
HindIII and NdeI and ligated into the pET 23a plasmid
(Novagen) cut with the same enzymes. All variants of β2m
were expressed and prepared as described previously
[47], with the modification that anion-exchange purification
buffers were used at pH 8.5 rather than pH 7.0 and gel
filtration was performed in 10 mM sodium phosphate
(pH 8.5) rather than 25 mM Tris HCl (pH 8.0) [47].Fibril growth experiments
For all experiments lyophilised protein was dissolved
in water, sterile filtered (0.22 μMpore size, Millipore) and
diluted to 50 μM in fibril growth buffer (25 mM sodium
phosphate / 25 mM sodium acetate, pH 2.5). Additional
NaCl was added as indicated. Fibril growth was
monitored in Corning® 96-well polystyrene microtitre
plates sealed with clear polyolefin sealing film (STAR-
LAB) for seven days at 37 °C with agitation (200 rpm)
using 100 μl per sample. Seeded reactions were
performed using 10% seeds (w/w), in which fibrils were
fragmented to create seeds by stirring at 1000 rpm as
described previously [39]. Fibril growth was assessed by
measuring the fluorescence of ThT (10 μM) (excitation
440 nm, emission 480 nm) using a Fluorostar Optima,
BMG Labtech plate reader at 37 °C (50 readings/well).
Fluorescence intensity is shown corrected for the signalof ThT in buffer alone and all data were normalised to the
final ThT signal. The resulting curves were used to
determine the lag times and apparent rates of elonga-
tion. The lag time was obtained by fitting a straight line to
the steepest part of the slope of the growth phase
(approximately 30% to 70% of the maximum amplitude),
and the time at which this line intersected the baseline
was taken as the lag time [37]. Synthetic peptides were
supplied by Peptide Protein Research Ltd as a pure
lyophilised powder and were dissolved in 100% DMSO.
The stock solutions were then diluted into the fibril
growth buffer. A final peptide concentration of 100 μM
was used with a final concentration of ≤ 5% (v/v) DMSO.Circular dichroism
CD experiments were performed on a Chirascan plus
spectrometer (Applied PhotoPhysics), with a bandwidth of
1 nm, scan speed of 20 nm min−1, step size of 1 nm and a
path length of 1 mm. An average of 4 scans was used for
the final spectra. Spectra were recorded using a protein
concentration of 0.2 mg/ml at 25 °C. Protein samples were
incubated after acidification at 37 °C for at least 20 minutes
and the CD spectra were then measured.ANS binding
The fluorescenceemission spectra of ANS (Sigma-Aldrich)
in the presence or absence of protein were recorded on a
Photon Technology International (PTI) QM-1 spectrofluo-
rimeter at 37 °C. Protein samples (10 μM) were prepared
and diluted into the relevant buffer or solution that also
contained ANS (250 μM final concentration). The fluores-
cence of ANS was determined immediately using an
excitationwavelength of 389 nm and fluorescence emission
was collected between 400 and 600 nm using slit widths of
5 nm.The fluorescenceemission of ANS in buffer alonewas
then used to normalise spectra from different buffer
conditions.Negative-stain EM
Carbon-coated copper grids were prepared by the
application of a thin layer of formvar with an overlay of
carbon. Protein samples (10 μl) were applied drop wise.
The grid was thin dried with filter paper before washing with
2 x 10 μl of deionised water, blotting with filter paper
between steps. Negative staining was achieved by the
addition of 10 μl of 2% (w/v) uranyl acetate, which was
subsequently blotted with filter paper. A second addition of
10 μl of 2% (w/v) uranyl acetate was allowed to stain for
30 seconds before blotting on filter paper. Micrographs
were recorded on a JOEL JEM-1400 electron microscope
equipped with a Gatan Orius camera.Sedimentation velocity AUC
Sedimentation velocity experiments were carried out
at 25 °C using a Beckman Optima XL-I analytical
ultracentrifuge (Beckman, Palo Alto, CA) using an
641Protein solubility and amyloid formationAn-60 Ti rotor with conventional aluminium double-sec-
tor centrepieces with a rotor speed of 48,000 rpm.
Samples of 50 μM protein were prepared by exchanging
the sample into the relevant buffer by overnight dialysis
at 4 °C. Radial absorbance scans at 280 nm were
collected at 300 s intervals and the data were analysed
using SEDFIT [48].NMR spectroscopy
All NMR experiments were carried out at 25 °C using
Varian Unity Inova spectrometers operating at 1H frequen-
cy of 500 MHz. Protein samples were prepared in buffer or
water with 10 % (v/v) D2O. Gradient enhanced
1H-15N
HSQC spectra were acquired using 160 complex points
and 16 scans per increment with spectral widths of
8511 Hz and 1800 Hz in the 1H and 15N dimensions,
respectively. Watergate solvent suppression was used,
and all NMR data were processed using NMRPipe and
analysed in NMRView [49,50].Solubility assay
Proteins were incubated at 50 μM in fibril growth buffer
(25 mM sodium phosphate/25 mM sodium acetate,
pH 2.5) with the addition of NaCl as indicated. Samples
were incubated at 200 rpm for two weeks at 37 °C
(500 μl in a 1.5 ml Eppendorf tube), before being
centrifuged at 14,000 g for 30 minutes on a bench top
centrifuge. The soluble protein was measured by
Bicinchoninic Acid (BCA) assay, or absorbance at
280 nm. An extinction coefficient of 18575 M−1 cm−1
was used to measure the protein concentration of mβ2m
in the absence of NaCl. A microBCA (Pierce Biotech-
nology Inc) assay was performed to measure the
supernatant concentrations of the other samples due to
their low critical concentrations. The “test tube” protocol
for the microBCA assay was followed, but reagent
volumes were reduced to measure 100 μl protein
samples. To determine the Cs, curves were fitted to
Eq. (1), where X is the initial protein concentration, Cs is
the plateau concentration and K is the protein concen-
tration value at half height of the curve.
Signal ¼ Csð ÞX
K þ X ð1Þ
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